VCAST technology with European patent – a breakthrough in AI-based cardiac imaging
Kardiolytics, a subsidiary of Medicalgorithmics, has been granted a European patent for its method of numerical modeling of blood flow in arteries. This solution, which has been under patent protection in the United States since April 2024, constitutes a key component of the VCAST technology developed by the company. VCAST leverages artificial intelligence algorithms to analyze cardiac computed tomography (CT) scans. Obtaining the European patent marks a significant milestone in the commercialization of the technology within the EU. The company estimates that VCAST, which received CE certification in mid-October 2024, could generate approximately PLN 130 million in revenue by 2028.